Hyperemesis Gravidarum Risk Reduction With Metformin

Recruiting

Phase 1

Phase 2

Metformin-XRHyperemesis Gravidarum Risk Reduction With Metformin

Sponsor:

University of Southern California

Code:

NCT07129473

Conditions

Hyperemesis Gravidarum

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Accepted

Interventions

Metformin Extended Release Oral Tablet

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-10. This information was provided to ClinicalTrials.gov by University of Southern California on 2026-07-22.